Iintlobo zesampulu: Amathe
Ixesha lovavanyo: imizuzu eyi-15
Uvakalelo: 98.10%
Iinkcukacha:>99.33%
Ikhithi yoVavanyo lwe-COVID-19 ye-Antigen ye-AMDNA12
I-AMDNA12 yezonyango ye-COVID-19 ye-Antigen yoVavanyo lwe-Saliva ye-Antigen isetyenziselwa ukufunyaniswa ngokomgangatho we-antigen yenoveli (i-COVID-19) kwisampulu yamathe, kuphela kusetyenziso loxilongo lwe-in vitro.
Ikhithi yoVavanyo lwe-COVID-19 ye-Antigen isetyenziselwa ukufunyaniswa ngokomgangatho we-antigen yenoveli (i-COVID-19) kwisampulu yamathe, kuphela kusetyenziso loxilongo lwe-in vitro.
Inoveli coronaviruses yeyodidi lwe-β.I-COVID-19 sisifo esosulelayo esinamandla sokuphefumla.Ngokuqhelekileyo abantu basengozini.Okwangoku, izigulana ezosulelwe yinoveli coronavirus ngoyena mthombo wosulelo;abantu abosulelekileyo abangenazimpawu nabo banokuba ngumthombo wosulelo.
Ikhithi yoVavanyo lwamathe ye-COVID-19 ye-Antigen ye-AMDNA12
Ngokusekelwe kuphando lwangoku lwe-epidemiological, ixesha lokufukamela yi-1 ukuya kwiintsuku ze-14, ubukhulu becala iintsuku ezi-3 ukuya kwezi-7.Iimpawu eziphambili ziquka umkhuhlane, ukukhathala kunye nokukhwehlela okomileyo.Ukuxinana kweempumlo, impumlo evuzayo, umqala obuhlungu, i-myalgia kunye ne-diarrhea zifumaneka kwiimeko ezimbalwa.I-Antigen ibonakala ngokubanzi kwiisampuli eziphezulu zokuphefumla ngexesha lesigaba esinzima sosulelo.
Ukufunyaniswa ngokukhawuleza kosulelo lwe-SARS-CoV-2 kuya kunceda abaqeqeshi bezempilo ukunyanga abaguli kwaye balawule esi sifo ngokufanelekileyo nangempumelelo.
Ikhithi yoVavanyo lwamathe ye-COVID-19 ye-Antigen ye-AMDNA12 isekwe kumgaqo-nkqubo wokusabela ngokuthe ngqo kwe-antibody-antigen kunye ne-colloidal yegolide yokuleyibhela itekhnoloji yohlalutyo lwe-immunochromatographic.I-reagent ine-COVID-19 ye-monoclonal antibody prefixed kwindawo yovavanyo (T) kwinwebu kunye ne-COVID-19 ye-monoclonal antibody eqatywe kwileyibhile yomxube wegolide we-pad-colloidal.
Ikhithi yoVavanyo lwamathe ye-COVID-19 ye-Antigen ye-AMDNA12
Isampulu ithontsizwa kwisampulu kakuhle kwaye idibana ne-COVID-19 monoclonal antibody ebotshelelwa kumasuntswana egolide e-colloidal ngaphambili xa kuvavanywa.Emva koko umxube we-chromatographed phezulu kunye nemiphumo ye-capillary.Ukuba ilungile, i-antibody ebhalwe ngamasuntswana egolide e-colloidal iya kuqala kubophelela kwintsholongwane ye-COVID-19 kwisampulu ngexesha lechromatography.Emva koko i-conjugates ibotshelelwe yi-COVID-19 monoclonal antibody ebekwe kwi-membrane, kwaye umgca obomvu uvela kwindawo yovavanyo (T).Ukuba ayinayo, akukho mgca ubomvu kwindawo yovavanyo (T).Nokuba isampuli iqulethe i-antigen ye-COVID-19 okanye hayi, umgca obomvu uya kuvela kwindawo yolawulo lomgangatho (C).
Umgca obomvu obonakala kwindawo yokulawula umgangatho (C) ngumgangatho wokugweba ukuba kukho iisampuli ezaneleyo kunye nokuba inkqubo yechromatographic iyinto eqhelekileyo, kwaye isebenza njengomgangatho wolawulo lwangaphakathi kwi-reagent.
Ikhithi yoVavanyo lwamathe ye-COVID-19 ye-Antigen ye-AMDNA12 Iimpawu:
Iintlobo zesampulu: Amathe
Ixesha lovavanyo: imizuzu eyi-15
Uvakalelo: 98.10%
Iinkcukacha:>99.33%
Amacandelo e-Medical COVID-19 Antigen Saiva Test Kit AMDNA12 strip kwikhasethi:
Isampulu iphedi: iqulethe iityuwa ezithintelweyo kunye nezicoci.
Iphedi yelebhile: iqulethe imouse ebhalwe ngegolide echasene ne-COVID-19 monoclonal antibody.Nitrocellulose inwebu:
Indawo yokulawula: iqulethe i-anti-mouse ye-IgG ye-polyclonal antibody kunye ne-buffer.Indawo yovavanyo: iqulethe i-anti-COVID-19 ye-monoclonal antibody kunye nesithinteli.Iphedi yokufunxa: yenziwe ngephepha elifunxa kakhulu.
